Lipitor and Brukinsa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Brukinsa (zanubrutinib). Common drug interactions include dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Brukinsa. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,048 Lipitor users. Check the latest studies of Lipitor.

What is Brukinsa?

Brukinsa has active ingredients of zanubrutinib. eHealthMe is studying from 1,334 Brukinsa users. Check the latest studies of Brukinsa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

12 people who take Lipitor and Brukinsa together, and have interactions are studied.

What are the common drug interactions of Lipitor and Brukinsa, by gender? *:

female:

n/a

male:

Dyspnoea (difficult or laboured respiration)
Pneumonia
Dysphonia (speech disorder attributable to a disorder of phonation)
Headache (pain in head)
Hyperkeratosis (thickening of the outer layer of the skin)
Impaired healing
Malaise (a feeling of general discomfort or uneasiness)
Respiratory tract infection
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Subdural haemorrhage (bleeding between the skull and the surface of the brain)

What are the common drug interactions of Lipitor and Brukinsa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Pneumonia
Dysphonia (speech disorder attributable to a disorder of phonation)
Headache (pain in head)
Hyperkeratosis (thickening of the outer layer of the skin)
Impaired healing
Malaise (a feeling of general discomfort or uneasiness)
Respiratory tract infection
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Subdural haemorrhage (bleeding between the skull and the surface of the brain)

What are the existing conditions these people have? *

Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 25.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 25.00%
Immunodeficiency Common Variable: 2 people, 16.67%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 8.33%
Hair Loss: 1 person, 8.33%
Blood Pressure Abnormal: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Brukinsa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously